Pharmaceutical Waste Sample Clauses

Pharmaceutical Waste. Any viable product which does not result in credit for the Member will be considered pharmaceutical waste and will not be limited by Vendor. Pharmaceutical waste will be disposed of according to applicable federal, state, and local guidelines and charged per pound, regardless of controlled schedule. Vendor will provide a certificate of destruction within 60 business days from the time the product was received and properly destroyed. The Vendor will become the waste generator and assume responsibility for the legal handling of all non-returnable products. A separate waste report shall be generated and available for controlled non-creditable products, non- controlled non-creditable products, and for hazardous non-creditable products.
AutoNDA by SimpleDocs
Pharmaceutical Waste. 4.6.1 Pharmaceutical waste includes, but is not limited to, expired, unused, spilt, and contaminated pharmaceutical products, drugs, vaccines, and sera that are no longer required and need to be disposed of appropriately.
Pharmaceutical Waste. Pharmaceutical waste is defined as non-creditworthy pharmaceutical product, and may include repackaged, unit dose, and blister packed products that may contain patient information. If pharmaceutical waste contains patient information, Vendor will follow all applicable provisions to safeguard this information under the Health Insurance Portability and Accountability Act (HIPAA). Vendor may not limit the amount of waste returned by the Member. All non-credit worthy product will be disposed of according to applicable federal, state, and local guidelines and charged per pound, regardless of controlled schedule. Vendor will provide a Certificate of Destruction on the web portal within 10 business days from when the product was received and properly destroyed. The Vendor will become the waste generator and assume responsibility for the legal handling of all non-returnable products. Vendor’s representative shall witness the destruction of all controlled and non-controlled pharmaceutical products. A separate waste report shall be generated and available for controlled non-creditable products, non-controlled non- creditable products, and for hazardous non-creditable products.

Related to Pharmaceutical Waste

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Dangerous Goods, Special Wastes, Pesticides and Harmful Substances Where employees are required to work with or are exposed to any dangerous good, special waste, pesticide or harmful substance, the Employer shall ensure that the employees are adequately trained in the identification, safe handling, use, storage, and/or disposal of same.

  • Chemical Substances Supplier warrants that: (i) each chemical substance contained in Products is on the inventory of chemical substances compiled and published by the Environmental Protection Agency pursuant to the Toxic Substances Control Act and (ii) all Material Safety Data Sheets required to be provided by Supplier for Products shall be provided to DXC prior to shipment of the Products and shall be complete and accurate.

  • Chemicals All chemicals are provided by Xxxxxxxx Pools & Spas at additional costs per the agreement. These include, but are not limited to, sanitizer, balancing chemicals, algaecide, & cleaners. 4.

  • SUBSTANCE ABUSE The dangers and costs that alcohol and other chemical abuses can create in the electrical contracting industry in terms of safety and productivity are significant. The parties to this Agreement resolve to combat chemical abuse in any form and agree that, to be effective, programs to eliminate substance abuse and impairment should contain a strong rehabilitation component. The local parties recognize that the implementation of a drug and alcohol policy and program must be subject to all applicable federal, state, and local laws and regulations. Such policies and programs must also be administered in accordance with accepted scientific principles, and must incorporate procedural safeguards to ensure fairness in application and protection of legitimate interests of privacy and confidentiality. To provide a drug-free workforce for the Electrical Construction Industry, each IBEW local union and NECA chapter shall implement an area-wide Substance Abuse Testing Policy. The policy shall include minimum standards as required by the IBEW and NECA. Should any of the required minimum standards fail to comply with federal, state, and/or local laws and regulations, they shall be modified by the local union and chapter to meet the requirements of those laws and regulations.

  • TOXIC SUBSTANCES Each Contractor furnishing a toxic substance as defined by Section 875 of the Labor Law, shall provide such Authorized User with not less than two copies of a material safety data sheet, which sheet shall include for each such substance the information outlined in Section 876 of the Labor Law. Before any chemical product is used or applied on or in any building, a copy of the product label and Material Safety Data Sheet must be provided to and approved by the Authorized User agency representative.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Chemical Dependency Alcoholism and drug addiction shall be recognized as an illness. However, sick leave pay for treatment of such illness shall be contingent upon two conditions: 1) the employee must undergo an evaluation by a licensed alcohol and drug counselor or substance abuse professional, and 2) the employee, during or following the above care, must participate in a prescribed program of treatment and rehabilitation approved by the Employer in consultation with the Employer's health care provider.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

  • Substance Abuse Program The SFMTA General Manager or designee will manage all aspects of the FTA-mandated Substance Abuse Program. He/she shall have appointing and removal authority over all personnel working for the Substance Abuse Program personnel, and shall be responsible for the supervision of the SAP.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!